Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 1
1984 3
1985 1
1986 1
1987 9
1988 1
1989 3
1990 5
1991 6
1992 7
1993 10
1994 1
1995 10
1996 3
1997 10
1998 10
1999 2
2000 5
2001 12
2002 9
2003 12
2004 11
2005 13
2006 9
2007 13
2008 13
2009 14
2010 18
2011 13
2012 15
2013 23
2014 11
2015 7
2016 24
2017 17
2018 15
2019 14
2020 10
2021 20
2022 7
2023 13
2024 16
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Results by year

Filters applied: . Clear all
Page 1
Anti-Jo-1 antibodies.
Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Zampieri S, et al. Autoimmunity. 2005 Feb;38(1):73-8. doi: 10.1080/08916930400022640. Autoimmunity. 2005. PMID: 15804708 Free article.
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). ...
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammat …
[Significance of anti-Jo-1 antibody's clinical stratification in idiopathic inflammatory myopathy and disease spectrum].
Li JC, Lai ZH, Shao M, Jin YB, Gao XJ, Zhang K, Hou J, Zhang YY, Li ZG, Li YH. Li JC, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Dec 18;55(6):958-965. doi: 10.19723/j.issn.1671-167X.2023.06.002. Beijing Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38101775 Free PMC article. Chinese.
In the analysis of ASS subgroups, the group with positive serum anti-Jo-1 antibody had a younger age of onset than those with negative serum anti-Jo-1 antibody (49.9 years vs. 55.0 years, P=0.026). ...CONCLUSION: The disease …
In the analysis of ASS subgroups, the group with positive serum anti-Jo-1 antibody had a younger age of onset th …
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome.
Pecher AC, Hensen L, Klein R, Schairer R, Lutz K, Atar D, Seitz C, Stanger A, Schneider J, Braun C, Schmidt M, Horger M, Bornemann A, Faul C, Bethge W, Henes J, Lengerke C. Pecher AC, et al. JAMA. 2023 Jun 27;329(24):2154-2162. doi: 10.1001/jama.2023.8753. JAMA. 2023. PMID: 37367976 Free PMC article.
MAIN OUTCOMES AND MEASURES: The patient's response to therapy was followed by magnetic resonance imaging of the thigh muscle, Physician Global Assessment, functional muscle and pulmonary tests, and peripheral blood quantification of anti-Jo-1 antibody …
MAIN OUTCOMES AND MEASURES: The patient's response to therapy was followed by magnetic resonance imaging of the thigh muscle, Physician Glob …
Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
Yang H, Chen Q, Sun C, Jin Q, Zhang L, Liu Q, Peng Q, Wang G, Lu X. Yang H, et al. Respir Res. 2024 May 29;25(1):222. doi: 10.1186/s12931-024-02851-w. Respir Res. 2024. PMID: 38811943 Free PMC article.
OBJECTIVE: To investigate the association of serum anti-Jo-1 antibody levels with the disease activity and prognosis in anti-Jo-1-positive patients with antisynthetase syndrome (ASS). ...Baseline anti-Jo-1 antibody levels we …
OBJECTIVE: To investigate the association of serum anti-Jo-1 antibody levels with the disease activity and progn …
COVID-19 vaccination-associated anti-Jo-1 syndrome.
Gupta K, Sharma GS, Kumar A. Gupta K, et al. Reumatologia. 2021;59(6):420-422. doi: 10.5114/reum.2021.111836. Epub 2021 Dec 14. Reumatologia. 2021. PMID: 35079187 Free PMC article.
The patient was further found to be positive for anti-Jo-1 antibody. The initial treatment was glucocorticosteroids and methotrexate initially. ...
The patient was further found to be positive for anti-Jo-1 antibody. The initial treatment was glucocorticostero …
Clinical spectrum of anti-Jo-1-associated disease.
Monti S, Montecucco C, Cavagna L. Monti S, et al. Curr Opin Rheumatol. 2017 Nov;29(6):612-617. doi: 10.1097/BOR.0000000000000434. Curr Opin Rheumatol. 2017. PMID: 28796005 Review.
Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
Yamaguchi K, Tang Q, Poland P, Reay DP, Gregory A, Aggarwal R, Oddis CV, Ascherman DP. Yamaguchi K, et al. Front Immunol. 2024 Jun 4;15:1399451. doi: 10.3389/fimmu.2024.1399451. eCollection 2024. Front Immunol. 2024. PMID: 38895121 Free PMC article.
RESULTS: Mice immunized with HRS had higher levels of anti-Ro52 and anti-Ro60 antibodies in serum and BALF than PBS-immunized mice. In 177 anti-Jo-1 antibody-positive patients, the prevalence of anti-Ro52 and anti-Ro60 antibodies was 36% and 15%, respe …
RESULTS: Mice immunized with HRS had higher levels of anti-Ro52 and anti-Ro60 antibodies in serum and BALF than PBS-immunized mice. In 177 …
389 results